Abstract:Microdamage accumulation contributes to impaired skeletal mechanical integrity. The bone can remove microdamage by initiating targeted bone remodeling. However, the spatiotemporal characteristics of microdamage initiation and propagation and their relationship with bone remodeling in response to fatigue loading, especially for more physiologically relevant daily bouts of compressive loading, remain poorly understood. The right forelimbs of 24 rats were cyclically loaded with a ramp waveform for 1,500 cycles/da… Show more
“…The fatigue may give rise to the microdamage in the skeleton mineralized matrix, and ensuing larger bone lesions, ultimately leading to obvious fracture 4,64 . Data analysis has shown that strains of 8000 microstrains enhanced a remarkably increased osteocyte apoptosis in ulnae of rodents 65 . Similarly, it has been indicated that osteocytes will undergo apoptosis once the fatigue induces bone structural microdamage upon overloading 4,64 .…”
Section: Microdamage and Plasma Membrane Disruptionmentioning
Vital osteocytes have been well known to function as an important orchestrator in the preservation of robustness and fidelity of the bone remodeling process. Nevertheless, some key pathological factors, such as sex steroid deficiency and excess glucocorticoids, and so on, are implicated in inducing a bulk of apoptotic osteocytes, subsequently resulting in resorption-related bone loss. As much, osteocyte apoptosis, under homeostatic conditions, is in an optimal state of balance tightly controlled by pro- and anti-apoptotic mechanism pathways. Importantly, there exist many essential signaling proteins in the process of osteocyte apoptosis, which has a crucial role in maintaining a homeostatic environment. While increasing in vitro and in vivo studies have established, in part, key signaling pathways and cross-talk mechanism on osteocyte apoptosis, intrinsic and complex mechanism underlying osteocyte apoptosis occurs in various states of pathologies remains ill-defined. In this review, we discuss not only essential pro- and anti-apoptotic signaling pathways and key biomarkers involved in these key mechanisms under different pathological agents, but also the pivotal role of apoptotic osteocytes in osteoclastogenesis-triggered bone loss, hopefully shedding new light on the attractive and proper actions of pharmacotherapeutics of targeting apoptosis and ensuing resorption-related bone diseases such as osteoporosis and fragility fractures.
“…The fatigue may give rise to the microdamage in the skeleton mineralized matrix, and ensuing larger bone lesions, ultimately leading to obvious fracture 4,64 . Data analysis has shown that strains of 8000 microstrains enhanced a remarkably increased osteocyte apoptosis in ulnae of rodents 65 . Similarly, it has been indicated that osteocytes will undergo apoptosis once the fatigue induces bone structural microdamage upon overloading 4,64 .…”
Section: Microdamage and Plasma Membrane Disruptionmentioning
Vital osteocytes have been well known to function as an important orchestrator in the preservation of robustness and fidelity of the bone remodeling process. Nevertheless, some key pathological factors, such as sex steroid deficiency and excess glucocorticoids, and so on, are implicated in inducing a bulk of apoptotic osteocytes, subsequently resulting in resorption-related bone loss. As much, osteocyte apoptosis, under homeostatic conditions, is in an optimal state of balance tightly controlled by pro- and anti-apoptotic mechanism pathways. Importantly, there exist many essential signaling proteins in the process of osteocyte apoptosis, which has a crucial role in maintaining a homeostatic environment. While increasing in vitro and in vivo studies have established, in part, key signaling pathways and cross-talk mechanism on osteocyte apoptosis, intrinsic and complex mechanism underlying osteocyte apoptosis occurs in various states of pathologies remains ill-defined. In this review, we discuss not only essential pro- and anti-apoptotic signaling pathways and key biomarkers involved in these key mechanisms under different pathological agents, but also the pivotal role of apoptotic osteocytes in osteoclastogenesis-triggered bone loss, hopefully shedding new light on the attractive and proper actions of pharmacotherapeutics of targeting apoptosis and ensuing resorption-related bone diseases such as osteoporosis and fragility fractures.
“…Herein, we employed a daily ulnar uniaxial compression session model developed by our group, 27 , 28 which mimics the fatigue damage accumulation in soldiers and athletes during physical training. Another single compression session model was also used to compare the “self-repair” rate of post-fatigue damage in various interventions.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, efficient approaches to early protection against bone stress injuries were explored by applying intervention before fatigue loading based on a rat ulnar axial compression model. 22 , 27 , 28 First, we investigated the effectiveness of anabolic PTH and anti-catabolic alendronate (ALN) (two common anti-osteoporotic agents), 29 as well as low-frequency electromagnetic fields (EMFs) and whole-body vibration (WBV), two biophysical modalities with reported osteogenic potential, 30 , 31 on the early prevention of bone stress injuries, and we also optimized the dosage and administration times. We further compared the effects of individual and combinational pharmaceutical/biophysical stimulation on early protection against microdamage accumulation to determine the optimal strategy.…”
“…To establish the hind-limb unloading (HU) model, mice were maintained in an approximately 30° head-down-tilt position by tail suspension using a custom-designed Plexiglas cage for 4 weeks. Then, the right tibiae of mice were subjected to daily uniaxial cyclic compressive loading for 2 weeks (5 d/wk) using a custom-designed mechanical loading system as described previously ( 29 , 51 ). The contralateral left tibiae were not loaded and were used as controls.…”
Disuse osteoporosis is a metabolic bone disease resulted from skeletal unloading (e.g., during extended bed rest, limb immobilization, and spaceflight), and the slow and insufficient bone recovery during re-ambulation remains an unresolved medical challenge.Here, we demonstrated that loading-induced increase in bone architecture/strength was suppressed in skeletons previously exposed to unloading. This reduction in bone mechanosensitivity was directly associated with attenuated osteocytic Ca 2+ oscillatory dynamics. The unloading-induced compromised osteocytic Ca 2+ response to reloading resulted from the HIF-1α/PDK1 axis-mediated increase in glycolysis, and a subsequent reduction in ATP synthesis. HIF-1α also transcriptionally induced substantial glutaminase 2 expression and thereby glutamine addiction in osteocytes. Inhibition of glycolysis by blocking PDK1 or glutamine supplementation restored the mechanosensitivity in those skeletons with previous unloading by fueling the tricarboxylic acid cycle and rescuing subsequent Ca 2+ oscillations in osteocytes. Thus, we provide a mechanistic insight into disuse-induced deterioration of bone mechanosensitivity and a promising therapeutic approach to accelerate bone recovery after long-duration disuse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.